Health care stocks were declining pre-bell Thursday, with The Health Care Select Sector SPDR Fund (XLV) down 0.9% and the iShares Biotechnology ETF (IBB) 0.7% lower.
Takeda Pharmaceutical (TAK) shares were down more than 0.5% after the company reported lower fiscal Q4 core earnings.
Argenx (ARGX) stock was more than 8% lower after the company posted operating income that trailed analysts' expectations.
Stevanato Group (STVN) shares were up over 1% after the company reported higher Q1 adjusted earnings and revenue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.